The drugmaker continues to dominate the market for prescription weight-loss drugs in the U.S.
Summary from the MarketWatch news feed. Copyright belongs to MarketWatch.
Opens in a new tab, so Investz stays open.
Headlines and summaries come from publishers’ public news feeds and are shown with attribution and a link to the original. Investz does not write or endorse them and they are not investment advice. Disclosures.